Literature DB >> 21109148

Radiosurgical management of brain metastases.

Anthony L D'Ambrosio1, Chad DeYoung, Steven R Isaacson.   

Abstract

Stereotactic radiosurgery (SRS) should be considered in the comprehensive treatment paradigm for all patients with brain metastases. This technique has proven benefits for local tumor control in individuals with as many as 4 lesions, and when combined with structured radiographic follow-up, will likely preserve a better quality of life for appropriately selected patients. Institutions and physicians treating patients with brain metastases should have the capability of safely performing SRS and individual cases should be prospectively reviewed by multidisciplinary teams to provide the best comprehensive care.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21109148     DOI： 10.1016/j.nec.2010.08.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN： 1042-3680            Impact factor:   2.509


  5 in total

Review 1.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

2.  Outcome of cerebral arteriovenous malformations after linear accelerator reirradiation.

Authors:  Paulo L Moraes; Rodrigo S Dias; Eduardo Weltman; Adelmo J Giordani; Salomon Benabou; Helena R C Segreto; Roberto A Segreto
Journal:  Surg Neurol Int       Date:  2015-06-04

3.  Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases.

Authors:  Shelly Lwu; Pablo Goetz; Eric Monsalves; Mandana Aryaee; Julius Ebinu; Norm Laperriere; Cynthia Menard; Caroline Chung; Barbara-Ann Millar; Abhaya V Kulkarni; Mark Bernstein; Gelareh Zadeh
Journal:  Oncol Rep       Date:  2012-11-14       Impact factor: 3.906

4.  Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis.

Authors:  Ning Tang; Jun Guo; Qianqian Zhang; Yali Wang; Zhehai Wang
Journal:  Oncotarget       Date:  2016-01-19

5.  Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial.

Authors:  Denise Bernhardt; Adriane Hommertgen; Daniela Schmitt; Rami El Shafie; Angela Paul; Laila König; Johanna Mair-Walther; Johannes Krisam; Christina Klose; Thomas Welzel; Juliane Hörner-Rieber; Jutta Kappes; Michael Thomas; Claus Peter Heußel; Martin Steins; Meinhard Kieser; Jürgen Debus; Stefan Rieken
Journal:  Trials       Date:  2018-07-16       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.